ClinicalTrials.gg
Not yet recruitingNCT07900269Updated Oct 28, 2026

Effect of Stress Ball Use on Perioperative Anxiety and Postoperative Pain in Parturients Undergoing Cesarean Section

An interventional study of stress ball squeezing in Postoperative Pain, sponsored by The Second Affiliated Hospital of Chongqing Medical University. Not yet recruiting at 1 site in China. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by The Second Affiliated Hospital of Chongqing Medical University · Not applicable, Interventional, and Prevention

Updated Oct 28, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
208
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 248 studies in Pain, Postoperative with a site in China — 78 open to participants now, 80 under way, 3 of them phase 3. Pain, Postoperative · China.

Planned enrollment
55th of 205
208 · median 132
Started
2026
with 34 others
No phase
103 of 248
36 open now
Primary completion
2027-06
later than 64 of 79 live
Registered
247th of 248
by date
Lead sponsor
9 of 248
The Second Affiliated Hospital of Chongqing Medical University

Among the 248 studies in Pain, Postoperative with a site in China, this one is the 55th largest by planned enrollment of the 205 interventional ones that give a count, is one of 35 that started in 2026, is one of 103 with no phase, reaches primary completion later than 64 of the 79 other live ones, and was the 247th registered.

Pain, Postoperative

5,648 studies on the registry are indexed under Pain, Postoperative; 1,231 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

78 of the 248 studies in Pain, Postoperative with a site in China are open now. Recruiting first, the newest first:

73 more — sign in →

All 78 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 679 Pain, Postoperative studies recruiting now, 240 (35%) set no upper age limit and 329 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 248 studies in Pain, Postoperative with a site in China, or all of them as a file.
02

Study summary

This project aims to investigate whether the use of a stress ball during the perioperative period, as a non-invasive, drug-free, simple, and easy-to-implement intervention, can reduce the incidence of moderate-to-severe visceral pain within 24 hours after surgery in postpartum women.

Read the detailed description

Against the backdrop of persistently high cesarean section rates, postoperative pain has become an increasingly prominent issue. Pharmacological treatment is constrained by breastfeeding safety concerns, and women undergoing cesarean section, as a population susceptible to anxiety, are caught in a vicious cycle of anxiety and pain. Distraction-based interventions have shown favorable effects but have limitations. As a simple and non-invasive tool, the stress ball has been preliminarily shown in other surgeries to have the potential to relieve pain and anxiety; however, its application in the perioperative period of cesarean section remains unexplored. This study intends to conduct a randomized controlled trial to systematically evaluate the effects of squeezing a stress ball during the perioperative period of cesarean section on maternal anxiety and postoperative pain, aiming to provide a safe, economical, and easily scalable non-pharmacological adjunct intervention for enhanced recovery after cesarean section.

03

Conditions studied

  • Postoperative Pain

Keywords

  • anxiety
  • postoperative pain
  • cesarean section
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Scheduled for elective cesarean section under neuraxial anesthesia
  2. (ASA) physical status I-III
  3. Age: 18-45 years
  4. Gestational age ≥ 37 weeks
  5. Willing and able to understand and sign the form

Exclusion criteria

Exclusion Criteria:

  1. Prior definite diagnosis of severe mental illness, cognitive impairment, or inability to understand pain rating scales and cooperate with the investigator;
  2. Presence of preoperative chronic pain, or long-term use of analgesic drugs and psychotropic drugs (such as anxiolytics, antidepressants, etc.);
  3. Hand motor dysfunction (e.g., rheumatoid arthritis)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
208 participants (estimated)

Study arms

  • Experimental
    Stress Ball Group

    In the pre-anesthesia room, each patient receives a sterilized, palm-sized elastic stress ball. She is instructed to squeeze it tightly for 3 s, then relax, repeating this rhythm; she may add slow breathing or silently count 1-3 and use it as needed when anxious. Intervention starts on entering the pre-anesthesia room and lasts until the end of surgery. Four standardized 5-min periods are set: (1) after entering the pre-anesthesia room and completing pre-intervention data collection; (2) after entering the operating room and before neuraxial anesthesia; (3) after anesthesia is completed and vital signs are stable until before fetal delivery; (4) after fetal delivery until before the end of surgery. The minimum cumulative intervention time is 20 min per participant. After this dose, patients may continue as needed without interfering with vital sign monitoring, anesthesia, or surgical procedures, using the same squeeze-3-s/relax-3-s rhythm.

    Device: stress ball squeezing

  • No intervention
    Usual Care Group

    No stress ball is provided, no additional distraction intervention is administered, and only routine departmental care is given.

Interventions

  • Devicestress ball squeezing

    In the pre-anesthesia room, give the patient a sterilized, palm-sized elastic stress ball. Instruct her to repeatedly "squeeze for 3 s, then relax," optionally with slow breathing or silently counting 1-3, and to use it as needed when anxious. The intervention begins on entry into the pre-anesthesia room and continues until the end of surgery. Four standardized periods are set: (1) after entry into the pre-anesthesia room and completion of pre-intervention data collection; (2) after entry into the operating room and before neuraxial anesthesia; (3) after anesthesia completion and vital-sign stabilization until before fetal delivery; (4) after fetal delivery until before the end of surgery. In each period, continuous intervention lasts 5 min, with a minimum cumulative intervention time of 20 min per participant. After the minimum dose, the parturient may use the stress ball as needed for anxiety or discomfort if it does not interfere with monitoring, anesthesia, or surgery.

06

What researchers measure

Primary outcomes

  1. incidence of moderate to severe visceral pain within 24 hours postoperatively

    Numerical Rating Scale (NRS) for pain: minimum 0 (no pain), maximum 10 (worst imaginable pain); higher scores indicate a worse outcome (greater pain intensity).The NRS scores for visceral pain at rest and during activity were assessed in parturients at 6 h , 12 h , and 24 h postoperatively. Moderate-to-severe visceral pain was defined as an NRS score of ≥4 (on a 0-10 scale) at any of these time points.

    Time frame: at 6 hours, 12 hours, and 24 hours after surgery

Secondary outcomes

  1. Frequency of rescue analgesic use within 24 hours postoperatively

    Time frame: within 24 hours after cesarean section

  2. The area under the curve (AUC) of NRS scores for visceral pain at rest and during activity within 24 hours postoperatively in parturients.

    Numerical Rating Scale (NRS) for pain: minimum 0 (no pain), maximum 10 (worst imaginable pain); higher scores indicate a worse outcome (greater pain intensity)

    Time frame: at 6 hours, 12 hours, and 24 hours after surgery

  3. Pre- and post-intervention 6-item STAI-S anxiety scores

    Six-item Short-Form State-Trait Anxiety Inventory (STAI-S6): the raw sum score ranges from 6 to 24.Higher scores indicate a worse outcome (greater state anxiety).

    Time frame: Pre-anesthesia , before operating room exit,at 6 hours、12 hours、and 24 hours after surgery

  4. NRS scores for visceral pain at rest and during activity within 24 hours postoperatively (at 6 h, 12 h, and 24 h after surgery)

    Numerical Rating Scale (NRS) for pain: minimum 0 (no pain), maximum 10 (worst imaginable pain); higher scores indicate a worse outcome (greater pain intensity).

    Time frame: at 6 hours, 12 hours, and 24 hours after surgery

  5. Hydromorphone equivalent dose within 24 hours after surgery

    Time frame: within 24 hours after cesarean section

  6. Effective PCIA pump presses within 24 h postop.

    The number of effective presses on the PCIA pump can be automatically counted by the pump's backend program.

    Time frame: within 24 hours after cesarean section

  7. score of pain sensitivity measurement

    For the pressure algometer used to measure pain sensitivity, the relevant metric is the Pressure Pain Threshold (PPT). There is no universal minimum or maximum: values are device- and probe-dependent (theoretical minimum 0; e.g., 0-2000 kPa for a 1 cm² probe or 0-4000 kPa for a 0.5 cm² probe). Higher PPT scores indicate a better outcome (lower pressure pain sensitivity), whereas lower scores indicate greater pain sensitivity.

    Time frame: before intervention in the pre-anesthesia room, immediately upon completion of surgery, and 24 hours postoperatively.

  8. NRS scores for incisional pain at rest and on movement within 24 hours after surgery.

    Numerical Rating Scale (NRS) for pain: minimum 0 (no pain), maximum 10 (worst imaginable pain); higher scores indicate a worse outcome (greater pain intensity).

    Time frame: at 6 hours, 12 hours, and 24 hours after surgery

  9. Postoperative adverse reactions

    Time frame: within 24 hours after cesarean section

  10. AUC of incisional pain NRS scores at rest and on movement within 24 hours after surgery.

    Numerical Rating Scale (NRS) for pain: minimum 0 (no pain), maximum 10 (worst imaginable pain); higher scores indicate a worse outcome (greater pain intensity).

    Time frame: at 6 hours, 12 hours, and 24 hours after surgery

  11. Changes in maternal heart rate during cesarean section.

    maternal heart rate (beats/min) wil be measured solely by the operating room monitor

    Time frame: during surgery: operating room entry, post-CSEA, skin incision, fetal delivery, skin closure

  12. Changes in maternal non-invasive blood pressure during cesarean section.

    non-invasive blood pressure (systolic/diastolic, mmHg) wil be measured solely by the operating room monitor

    Time frame: during surgery: operating room entry, post-CSEA, skin incision, fetal delivery, skin closure

  13. Changes in maternal pulse oxygen saturation during surgery.

    peripheral oxygen saturation (SpO₂, %) wil be measured solely by the operating room monitor

    Time frame: during surgery: operating room entry, post-CSEA, skin incision, fetal delivery, skin closure

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Jun 2027, 9 months later.

Of 2,096 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.

Counting every sponsor, half of 2,109 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 14, 2026
First posted
Oct 28, 2026
StartEst.
Sep 30, 2026
Primary completionEst.
Jun 30, 2027
CompletionEst.
Jun 30, 2027
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07900269
Responsible party
He Huang (professor, The Second Affiliated Hospital of Chongqing Medical University) — Principal investigator
First posted
Oct 28, 2026
Start date
Sep 30, 2026 (estimated)
Primary completion
Jun 30, 2027 (estimated)
Completion
Jun 30, 2027 (estimated)
Last update
Oct 28, 2026

Study contacts

He Huang
Contact
huanghe@cqmu.edu.cn
86+13708385559

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion